Results for
""Epoprostenol""[mesh_terms]

Understanding primary pulmonary hypertension.

Nancy Grimes Coyne, Diane Schleyer Berkowitz

Critical care nursing quarterly 2003;26(1):28-34

Primary pulmonary hypertension. World Health Organization.

A R Fauzi

The Medical journal of Malaysia 2001;55(4):529-37; quiz 538

Severe pulmonary hypertension: critical care clinics.

S Rich, V V McLaughlin

Critical care clinics 2001;17(2):453-67

Epoprostenol sodium for treatment of pulmonary arterial hypertension.

Yukihiro Saito, Kazufumi Nakamura, Satoshi Akagi, Toshihiro Sarashina, Kentaro Ejiri, Aya Miura, Aiko Ogawa, Hiromi Matsubara, Hiroshi Ito

Vascular health and risk management 2016;11():265-70

A mechanosensitive cation channel in endothelial cells.

H Y Kwan, Xiaoqiang Yao, Yu Huang

Journal of cardiac surgery 2003;17(4):340-1

Prostanoids for intermittent claudication.

Alina Andras, Lindsay Robertson

The Cochrane database of systematic reviews 2013;2013(4):CD000986

Update on pulmonary arterial hypertension pharmacotherapy.

Michael Shen, Marcos G Valerio, Sohaib Tariq, Gregg M Lanier, Wilbert S Aronow, Arash Velayati

Postgraduate medicine 2017;128(5):460-73

Treprostinil: new drug. Pulmonary artery hypertension: just another (disappointing) prostacycline analogue.

Prescrire international 2006;15(85):177-9

The effects of beraprost sodium on renal function and cardiometabolic profile in patients with diabetes mellitus: a systematic review and meta-analysis of clinical trials.

Peyman Nowrouzi-Sohrabi, Reza Tabrizi, Kamran Hessami, Mojtaba Shabani-Borujeni, Mahnaz Hosseini-Bensenjan, Shahla Rezaei, Mohammad Jalali, Pedram Keshavarz, Fariba Ahmadizar

International urology and nephrology 2022;54(1):111-120

Current and emerging therapy for primary pulmonary hypertension.

Michelle L Dusing, Steven E Pass

The Annals of pharmacotherapy 2003;36(9):1414-23

Pulmonary hypertension: new perspectives.

Steven W Stites, Trenton D Nauser

Congestive heart failure (Greenwich, Conn.) 2003;9(3):155-62

Studies on the effectiveness and safety of cilostazol, beraprost sodium, prostaglandin E1 for the treatment of intermittent claudication.

Ryoko Saito, Keiko Ohno, Masayuki Hashiguchi

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2004;124(6):321-32

N1-methylnicotinamide (MNAM) as a guardian of cardiovascular system.

Hamid Reza Nejabati, Aynaz Mihanfar, Masoud Pezeshkian, Amir Fattahi, Zeinab Latifi, Naser Safaie, Mohammad Valiloo, Ahmad Reza Jodati, Mohammad Nouri

Journal of cellular physiology 2019;233(10):6386-6394

In situ microdialysis of intramuscular prostaglandin and thromboxane in contracting skeletal muscle in humans.

M Karamouzis, H Langberg, D Skovgaard, J Bülow, M Kjaer, B Saltin

Acta physiologica Scandinavica 2001;171(1):71-6

Pulmonary arterial hypertension--the primary pulmonary hypertension syndromes.

Steven M Scharf, Jamie C Hey

The Israel Medical Association journal : IMAJ 2003;5(4):298-303